After months of tension, Apple’s court-appointed antitrust monitor reported an improved relationship with the technology giant and progress in antitrust compliance efforts.
According to reports, Michael Bromwich said his once “contentious” relationship with Apple has vastly improved, detailing the improvements in a report filed Monday to US District Judge Denise Cote. Judge Cote ordered Apple to work with Bromwich following a decision that found Apple had conspired to manipulate eBooks prices.
Following the monitor’s appointment, Apple had fought Bromwich’s position and requested that he be removed from his post on claims that he was overstepping his boundaries at the company.
In his filing, Bromwich said that since his appointment last October there had been “unexpected delays” in efforts to cooperate with Apple; the last six weeks, however, has shown vast improvements, with their relationship “more focused on achieving the goal of enhancing Apple’s Antitrust Compliance Program.”
While the filing appears to be good news for the company, Apple still faces $840 million in claims filed for the eBooks price-fixing collusion. A lawsuit is set for trial later this year.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan